Studies On The Preparation And Pharmacokinetics In Goat Of Doramectin Microballoons

Parasitosis is one of the most important diseases which could jeopardize the health of domestic animals and development of animal husbandry.Especially,the diseases which are caused by nemathelminth and exoparasite possess sizable proportion in parasitosis,can cause enormous loss to the animal husbandry,some parasites can infect human or as transmission intermediaries and jeopardize foods security and human health.Therefore,the prevention and treatment of parasitosis diseases in domestic animals not only can reduce the economic loss and offer the powerful guarantee to the development of animal husbandry,but also have important significance of medical science and public health.At present,doramectin is one of the best medicines to prevent and treat nemathelminth in vivo and exoparasite.As its single dosage form,it is often necessarily to be administered for several times in one production cycle,which caused the waste of manpower and thingpower.In order to possess excellent helminthicide effect and decrease the cost of animal husbandry production which is caused by the multiple administers.It is of great necessity to develop a new form of antiparasite drug which owns security,high performance and lasting effect.Microballoons of doramectin were prepared in this study,and the pharmacokinetics characteristics of the doramectin microballoon and the blank microballoon injections were compared with that of the common injections of doramectin in goats by HPLC.1.The lente liberantes gelatin microballoons of doramectin were prepared by emulsification-chemical crosslinking method,meanwhile,the optimal preparation technology was determined by single factors and orthogonal design test:the oil phase were prepared by adding 60mL of liquid paraffin and 1.5%span-80 emulsifier into a container of 250mL,put in 50℃aqueous bath;the water phase were made by dispersing 0.18g of doramectin into 12mL of 0.15g·mL^-1 gelatin solution,dropwised into the oil phase slowly with 400rpm·min^-1 agitating, emulsified for 15min,and ice bathed,agitated consecutively,and 3mL of glutaral was added inside, solidified for 30min,anhydrated by isopropanol,suction filtrated,washed by isopropanol, ethylether,and ice water for several times,then charged by air drying and cribration.2.The quality indexes such as particle size,appearance,clarity and insolubility grains were appraised for the prepared microballoons by light microscope.The results indicated that the mean diameter was 39.7108μm,the ratio of the particle diameter distributed within 20～50μm was 94.8%,the zero angle,θ=22.23°,the bulk density,ρ=0.6417g·mL^-1,the expansion coefficient, E=29.8567%,and the drug-loading,entrapment efficiency,recovery rate was 6.84%,72.75%and 94.68%,respectively,which were measured by UV spectrophotometer.The results indicated that the preparation technology was stable,and the microballoons had suitable grain size,smooth appearance,well-distributed,good stabilization and runnability.The drug loading and entrapment efficiency corresponded with the clinical application.3.The pharmacokinetics of the normal doramectin injection and the doramectin microballoon injection in goat were studied in this paper.The plasma drug concentration-time data was quantitated by means of HPLC and processed by MCPKP compartment analyzed procedure.The result showed that the limit of detection of doramectin in plasma was 1ng·mL^-1 in this experimental condition,the lineary correlation between the chromatographic peak-areas and the standard concentration was obtained at a wide concentration range of 1～100ng·mL^-1,and the linear equation of doramectin was y=12756x-10818,R²=0.9975.Three concentration levels(50,10, 1.0ng·mL^-1) of doramectin were analysised,the intra-day coefficient of variance was 2.81%,2.28% and 1.57%respectively,and the inter-day coefficient of variance was 2.65%,2.06%and 2.37% respectively,the average recovery valued 89.67%±3.05%,92.23%±2.47%,and 92.50%±3.23%, respectively.The procession of the doramectin solution and the microbailoon solution after single subcutaneous administration was coordinate with the one-compartment open model with the first-order absorption,the main pharmacokinetic parameters of the doramectin injection in goats were as follows:t_1/2ka=0.87±0.11d,t_1/2kb=6.67±0.46d,T_max=3.16±0.31d,C_max=28.70±1.29ng·mL^-1, AUC=378.36±29.86ng·d^-1·mL^-1,the main pharmacokinetic parameters of the doramection microballoon injection in goats were as follows:T_max=4.36±0.73d,C_max=33.87±2.52ng·mL^-1, AUC=1029±78.49ng·d^-1·mL^-1,the AUC of the microballoon injection was higher than that of the common doramectin injection.In conclusion,doramectin microballoons were successfully prepared to the purpose of delayed release.The pharmacokinetics was also better than the common ones.This study not only provided bases for reasonable application of the clinical veterinary,but provided theoretical bases for developing effective dosage regimen.